New method of therapeutic application of thalidomide used in anorexia nervosa

摘要

"A new form of therapeutic application to thalidomide used in anorexia nervosa.The present technique focuses on the nervous anorexia (an) and deliberate weight loss associated with anorexia and depression that affects mostly adolescents and young women (Western obsession with thinness).But an affects elderly women, children and men in all cultures and is accompanied by systemic complications (neuroendocrine, cardiovascular, diabetes, cancers, etc.).The treatment currently recommended by feeding or parenteral probe can trigger cardiovascular complications, electrolyte disturbances, etc. a fatal outcome. It is not known if the cause of the ANN.However, the ANN is the symptom of autoimmune disease, that is chronically high levels of cytokines that induce progressively loss of palatability, anorexia, cachexia,Anxiety / depression, DM, cancers, cardiovascular complications, etc. Thalidomide reduces the levels of cytokines pathologically increased.This patent relates to a new method of use for thalidomide is used in an in which highlights the application of this drug with reasoning technique in combination with anti immuneBioticoterapia, where the medicine is presented as an immunomodulator, reducing those pathologically increased levels of cytokines.With the normalization of the immune system and simultaneous treatment and / or prevention of serious complications and fatal, with minimal side effects or void, showing greater simplicity.The efficiency and effectiveness of the technique in the treatment of an immune restoration practice. The new invention refers to the use of thalidomide in an, such as: 1. Immunomodulator; 2.Use in with impressive results, 3. Doses above the usual; 4. The association with antibiotic therapy.